Pharmacologic Stress Agents Market – Global Industry Analysis, Market Size Estimation, Growth Forecast By Pharmacologic Agent Type (Adenosine, Regadenosone, Dipyridamole, Dobutamine), By Applications (Nuclear Imaging, Echocardiogram, Magnetic Resonance Imaging, Computed Tomography Scan) & By Regions, 2017 – 2025

The Pharmacologic Stress Agents Market report examines all parameters and forecasts the growth prospects in the research period from 2017 to 2025.

 
What Are the Driving Factors for the Growth of Pharmacologic Stress Agents Market Size?

  • Growing demand for different types of cardiovascular testing
  • Unhealthy lifestyle and food habits leading to growing health problems, heart conditions, and the healthcare professionals are using different types of testing procedure in detection
  • Development in technology

 

How Is This Market Segmented?
By Term Segments
By Pharmacologic Agent Type Adenosine, Regadenosone, Dipyridamole and Dobutamine
By Applications Nuclear Imaging, Echocardiogram, Magnetic Resonance Imaging, Computed Tomography Scan and Others
By Regions North America, Asia-Pacific, Europe, Middle East & Africa and Latin America

 

Who Are The Leading Competitors In This Market?
Headquarters Corporations
Japan Astellas Pharma, Inc.
The U.S. Gilead Sciences, Inc., Cardinal Health, Inc.
The U.K. Rapidscan Pharma Solutions, Inc.

 
Why Buy This Pharmacologic Stress Agents Market Report?

  • It provides in-depth analysis of market determinant factors.
  • It analyzes market dynamics for each segment (such as Pharmacologic Agent Type, Applications, Regions).
  • The report provides 8 years forecast by analyzing push and pull factors affecting the dynamics of the market.
  • This market report provides application level cross-sectional analysis for each product type.
  • It provides regional level pricing trend analysis.
  • The analysis acts as business decision support system by analyzing key trends in each market segment.
  • This research report provides insights regarding business strategies of leading market players.

Pharmacologic Stress Agents Market - Introduction

The global pharmacologic stress agents market is expected to grow at a fast pace during the forecast period 2017 to 2025. In the pharmacologic stress agents market report, the market is segmented based on drug type and region. Gout can be termed as a variant of arthritis and can either be acute or chronic. Pharmacologic stress agents are utilized for artificially inducing stress on the circulatory system, during pharmacologic stress testing. Pharmacologic stress testing is performed to monitor a heart condition or to find problems related to the heart and then to devise a treatment plan based on the found problems. Problems to be identified includes shortness of breath, chest pain, arrhythmia, and weakness among others. The market for pharmacologic stress agents is primarily being driven by the growing number of patients of cardiovascular diseases globally.

Report Overview
Aspect Details
Base Year of Estimation 2016
Value Estimation Year 2017
Forecast Period 2017 - 2025
Market Segmentations By Pharmacologic Agent Type, Applications, Regions
Regional Scope North America, Asia-Pacific, Europe, Middle East & Africa and Latin America
Report Coverage Market Dynamics, Segmentation Overview and Competitive Landscape of the market

 

Market Dynamics

As per the World Health Organization, 31% of global deaths, or deaths of 7.4 million persons approximately, were caused by cardiovascular diseases, in 2015. Additionally, of the 7.4 million deaths, 6.7 million deaths were due to stroke. Such widespread prevalence of cardiovascular disease is leading to growing demand for different types of cardiovascular testing. This, in turn, is fuelling the growth of pharmacologic stress agents market size.

The hectic and unhealthy lifestyle of people around the globe is leading to the development of several sorts of health problems and diseases, including diabetes mellitus. Unhealthy lifestyle leads to improper rest for the body and erratic food habits. Due to such growing health problems, heart conditions which were only found in persons above 60 years of age, are now being found in a 30-year-old person also. Hence, healthcare providers are continuously engaging in different types of testing, to determine the heart problems. This, in turn, has also been positively impacting the growth of the market for pharmacologic stress agents globally.

The rising cost of pharmacologic stress agents, coupled with the cost of stress testing, is a restraining factor for the growth of the market. As per WHO, 82% of the 7.4 million cardiovascular disease related deaths in 2015, were in low and middle-income countries. This suggests the high prevalence rate of such diseases in these countries. Hence, the patient population is often unable to bear the high cost of pharmacologic stress testing, leading to growth restraint for the pharmacologic stress agents market. However, with growing improvement in technology and due to the better results from these agents, such restraints are not expected to have a significant impact on the growth of the pharmacologic stress agents market, during the forecast period.

 

Segmentation Overview

By pharmacologic agent type, the global pharmacologic stress agents market is segmented into Adenosine, Regadenosone, Dipyridamole and Dobutamine. Adenosine and Regadenosone are two of the most popular stress agents and both function as coronary vasodilator, which increases coronary blood flow. On the basis of application, the global market for pharmacologic stress agents is segmented into nuclear imaging, echocardiogram (ECG), magnetic resonance imaging (MRI), Computed Tomography (CT) Scan and others.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa (MEA), and Latin America. In terms of revenue, North America accounted for the largest market share of the pharmacologic stress agents market, followed by Asia-Pacific. The presence of a large patient pool and advanced diagnostic centers are the primary growth driver for the North American market for pharmacologic stress agents.

 

Competitive Landscape

Major companies operating in the pharmacologic stress agents market are Astellas Pharma, Inc. (Japan), Gilead Sciences, Inc. (The U.S.), Rapidscan Pharma Solutions, Inc. (The U.K.), and Cardinal Health, Inc. (The U.S.) among others.

 

Related Upcoming Report Titles

Blood Pressure Monitoring Equipments Market Report- Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025: Factor & Equilibrium

Dietary Supplements Market Research- Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025: Factor & Equilibrium

Immunotherapy Drugs Market Analysis Report - Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025: Factor & Equilibrium

Contract Research Organization Market Report- Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025

Diet Management Products Market Analysis- Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025

Radiopharmaceuticals Market - Global Industry Insights, Market Size Estimation and Growth Forecast, Up to 2025

Weight Loss Products and Services Market Analysis Report - Global Industry Insights Up to 2025: Factor & Equilibrium

Get Free Samples for Market Research Reports. The privacy and security of your shared information are very important to us. Our website is secure and your personal details are safe.